Capital Fund Management S.A. Guardant Health, Inc. Call Options Transaction History

Capital Fund Management S.A.

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$17.13 - $26.91 $914,742 - $1.44 Million	-53,400 Reduced 72.46%	20,300 $418,000
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $1.36 Million - $1.86 Million	63,200 Added 601.9%	73,700 $1.99 Million
Q3 2023 Nov 14, 2023	BUY	$25.8 - $39.97 $2,580 - $3,997	100 Added 0.96%	10,500 $311,000
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $217,776 - $395,304	10,400 New	10,400 $372,000
Q3 2021 Nov 12, 2021	BUY	$98.77 - $132.17 $1.75 Million - $2.34 Million	17,700 New	17,700 $2.21 Million
Q2 2021 Aug 12, 2021	SELL	$109.77 - $165.68 $1.12 Million - $1.69 Million	-10,200 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$127.04 - $179.1 $1.3 Million - $1.83 Million	10,200 New	10,200 $1.56 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.24B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.